Treatment with stimulants and the risk of COVID-19 complications in adults with ADHD

Posted on | Posted on John Murphy | Leave a Comment on Treatment with stimulants and the risk of COVID-19 complications in adults with ADHD

Wen-Jan Tuan,a,⁎ Dara E. Babinski,b David P. Rabago,a,b,c and Aleksandra E. Zgierskac Abstract Adults with attention deficit hyperactivity disorder (ADHD) have shown higher infection rates and worse outcomes from COVID-19. Stimulant medications are prescribed as the first-line treatment for ADHD in adults and mitigate risk of negative ADHD-related health outcomes, but little is known about the association between stimulant […]

Conflicting Evidence Of mRNA Technology Raises Serious Concerns About Rush For Use In New Vaccine Development

Posted on | Posted on John Murphy | Leave a Comment on Conflicting Evidence Of mRNA Technology Raises Serious Concerns About Rush For Use In New Vaccine Development

Authored by Megan Redshaw via The Epoch Times, FRIDAY, SEP 01, 2023 The U.S. government and pharmaceutical companies are investing a substantial amount to develop new mRNA vaccines for infectious diseases and cancer, fueling a lucrative mRNA platform valued at $136.2 billion. A newly established White House program announced on Aug. 23 that it is granting a […]

Will BA.2.86 (‘Pirola’), the New Coronavirus Variant, Increase COVID-19 Cases?

Posted on | Posted on John Murphy | Leave a Comment on Will BA.2.86 (‘Pirola’), the New Coronavirus Variant, Increase COVID-19 Cases?

BY CARRIE MACMILLAN AUGUST 31, 2023 A new coronavirus variant is raising alarm, but much about it remains unknown Note: Information in this article was accurate at the time of original publication. Because information about COVID-19 changes rapidly, we encourage you to visit the websites of the Centers for Disease Control & Prevention (CDC), World Health Organization […]

Long COVID in the skin: a registry analysis of COVID-19 dermatological duration

Posted on | Posted on John Murphy | Leave a Comment on Long COVID in the skin: a registry analysis of COVID-19 dermatological duration

Devon E McMahon, Antonia E Gallman, George J Hruza, Misha Rosenbach, Jules B Lipoff, Seemal R Desai Published: January 15, 2021DOI:https://doi.org/10.1016/S1473-3099(20)30986-5 Lancet: VOLUME 21, ISSUE 3, P313-314, MARCH 2021 Since the start of the COVID-19 pandemic, multiple studies have reported that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is associated with dermatological manifestations.  However, data on duration […]

Potential Prophylactic Treatments for COVID-19

Posted on | Posted on John Murphy | Leave a Comment on Potential Prophylactic Treatments for COVID-19

Noam Ben-Zuk,1,† Ido-David Dechtman,2,3,† Itai Henn,1 Libby Weiss,1 Amichay Afriat,4 Esther Krasner,1,* and Yoav Gal1,5,*Kenneth Lundstrom, Academic Editor and Alaa A. A. Aljabali, Academic Editor Viruses. 2021 Jul; 13(7): 1292. Published online 2021 Jul 2. doi: 10.3390/v13071292 PMCID: PMC8310088 PMID: 34372498 Abstract The World Health Organization declared the SARS-CoV-2 outbreak a Public Health Emergency of International Concern at the end of January 2020 and a pandemic two months later. The […]

Doxycycline in the Coronavirus Disease 2019 Therapy

Posted on | Posted on John Murphy | Leave a Comment on Doxycycline in the Coronavirus Disease 2019 Therapy

Karolina Dorobisz, 1 Tadeusz Dorobisz, 2 Dariusz Janczak, 2 and Tomasz Zatoński 1 Author information Article notes Copyright and License information PMC Disclaimer Ther Clin Risk Manag. 2021; 17: 1023–1026. Published online 2021 Sep 21. doi: 10.2147/TCRM.S314923 PMCID: PMC8464303PMID: 34584416 Abstract Acute respiratory syndrome, associated with coronavirus 2 (SARS-CoV-2), is the most important medical and epidemic problem of today. The biggest challenge is to find an effective treatment and to reduce […]

Potential New Treatment for “Brain Fog” in Long COVID Patients

Posted on | Posted on John Murphy | Leave a Comment on Potential New Treatment for “Brain Fog” in Long COVID Patients

December 12, 2022 by Isabella Backman Individuals with long COVID, sometimes referred to as “long-haulers,” experience symptoms that may persist for weeks, months, or even years after their acute viral infection. While symptoms vary widely, a common complaint among patients is “brain fog”—a colloquial term for significant, persistent cognitive deficits, with consistent impairment of executive […]

Ritalin (Methylphenidate) For Chronic Fatigue Syndrome and Fibromyalgia

Posted on | Posted on John Murphy | Leave a Comment on Ritalin (Methylphenidate) For Chronic Fatigue Syndrome and Fibromyalgia

Methylphenidate (Ritalin, Concerta) Ritalin Is… a central nervous system stimulant. Created in 1954, Ritalin has been in use for over sixty years. (Check out a History of Ritalin here). It was first FDA approved in 1955 to treat ‘hyperactivity’ and later was approved to treat attention deficit hyperactivity disorder (ADHD). Ritalin increases extracellular levels of dopamine […]

New research helps explain how Ritalin sharpens attention

Posted on | Posted on John Murphy | Leave a Comment on New research helps explain how Ritalin sharpens attention

Date: April 29, 2022 Source: University of Pittsburgh Science Daily Summary: Researchers found animals that had taken methylphenidate performed better on a visual task of attention, and that the improvement happened exactly when that same metric of neuron activity shifted. Even half a century after a drug comes on the market, scientists can still learn […]

Exercise is the Most Important Medicine for COVID-19

Posted on | Posted on John Murphy | Leave a Comment on Exercise is the Most Important Medicine for COVID-19

Torres, Georgia PhD; Constantinou, Demitri MBChB, FACSM; Gradidge, Philippe PhD; Patel, Deepak MD; Patricios, Jon MBBCh, MMedSci Current Sports Medicine Reports 22(8):p 284-289, August 2023. | DOI: 10.1249/JSR.0000000000001092 Abstract COVID-19 infection and long COVID affect multiple organ systems, including the respiratory, cardiovascular, renal, digestive, neuroendocrine, musculoskeletal systems, and sensory organs. Exerkines, released during exercise, have a potent crosstalk effect […]